AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇲🇼
DOLUTEGRAVIR AND LAMIVUDINE in Malawi
1 product registered with PMRA — 0 active, 1 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| DOLUTEGRAVIR_AND_LAMIVUDINE 50/300MG TABLET TABLET | PMPB/PL167/192 | — | expired | 31 Mar 2024 |
DOLUTEGRAVIR AND LAMIVUDINE — PMRA Registration Details
PMRA (Malawi) has 1 registered product containing DOLUTEGRAVIR AND LAMIVUDINE, of which 0 are currently active. Data is sourced directly from the official PMRA drug register and refreshed daily.
Track DOLUTEGRAVIR AND LAMIVUDINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.